Literature DB >> 11971016

Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection.

Martin D Lehner1, Frank Schwoebel, Alexey Kotlyarov, Marcel Leist, Matthias Gaestel, Thomas Hartung.   

Abstract

Mitogen-activated protein kinase-activated protein kinase 2 (MK2) is one of several kinases activated through direct phosphorylation by p38 mitogen-activated protein kinase. MK2 regulates LPS-induced TNF mRNA translation, and targeted mutation of the MK2 gene renders mice more resistant to D-galactosamine plus LPS-induced liver damage. In the present study, we investigated the role of MK2 in immune defense against Listeria monocytogenes infection. MK2-deficient mice displayed diminished resistance to L. monocytogenes due to impaired control of bacterial growth. The increase in bacterial load in MK2(-/-) mice was associated with normal levels of IL-1 beta, IL-6, and IFN-gamma, whereas TNF production was strongly attenuated. In line, MK2-deficient bone marrow-derived macrophages showed impaired release of TNF, but not of IL-1 beta, in response to various bacterial stimuli in addition to decreased phagocytosis of fluorescence-labeled bacteria. Furthermore, spleen cells from MK2(-/-) mice displayed diminished IFN-gamma synthesis after stimulation with L. monocytogenes. In contrast, MK2 deficiency had no effect on macrophage generation of NO or on oxidative burst activity in response to L. moocytogenes. These results indicate an essential role of MK2 in host defense against intracellular bacteria probably via regulation of TNF and IFN-gamma production required for activation of antibacterial effector mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971016     DOI: 10.4049/jimmunol.168.9.4667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 2.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 3.  Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Authors:  Mazen M Jamil Al-Obaidi; Mohd Nasir Mohd Desa
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

4.  Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.

Authors:  Lale Ozcan; Xiaoming Xu; Shi-Xian Deng; Devram S Ghorpade; Tiffany Thomas; Serge Cremers; Brian Hubbard; Michael H Serrano-Wu; Matthias Gaestel; Donald W Landry; Ira Tabas
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

5.  MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages.

Authors:  Jianzhong Zhu; Xianzhu Wu; Suchi Goel; Nagaraj M Gowda; Sanjeev Kumar; Gowdahalli Krishnegowda; Gourav Mishra; Rebecca Weinberg; Guangfu Li; Matthias Gaestel; Tatsushi Muta; D Channe Gowda
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

6.  Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination.

Authors:  Yu Shi; Alexey Kotlyarov; Kathrin Laabeta; Achim D Gruber; Elke Butt; Katrin Marcus; Helmut E Meyer; Anke Friedrich; Hans-Dieter Volk; Matthias Gaestel
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

7.  p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin.

Authors:  Karl Katholnig; Christopher C Kaltenecker; Hiroko Hayakawa; Margit Rosner; Caroline Lassnig; Gerhard J Zlabinger; Matthias Gaestel; Mathias Müller; Markus Hengstschläger; Walter H Hörl; Jin Mo Park; Marcus D Säemann; Thomas Weichhart
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

8.  Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.

Authors:  Ragini Vittal; Amanda Fisher; Hongmei Gu; Elizabeth A Mickler; Alyssa Panitch; Cynthia Lander; Oscar W Cummings; George E Sandusky; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

9.  Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce.

Authors:  Brian Ward; Brandon L Seal; Colleen M Brophy; Alyssa Panitch
Journal:  J Pept Sci       Date:  2009-10       Impact factor: 1.905

Review 10.  Biological targets for therapeutic interventions in COPD: clinical potential.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Luca Gallelli; Teresa Renda; Mario Caputi; Rosario Maselli; Serafino A Marsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.